The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealing

9 Dec 2021 08:51

RNS Number : 1198V
Byotrol PLC
09 December 2021
 

 

Byotrol Plc

 

("Byotrol" or the "Company")

 

Director Dealing

 

Byotrol Plc, the specialist infection prevention and control company, is pleased to announce that the Company was notified on 08 December 2021 that on that same day, David Traynor, Chief Executive Officer of the Company, purchased 244,155 ordinary shares of 0.25p each ("Ordinary Shares") at an average price of 4.29p per Ordinary Share (the "Purchase").

 

Following the Purchase, David Traynor has an interest in 9,935,297 Ordinary Shares representing 2.19% of the total voting rights of the Company.

 

 

For further information contact:

 

Byotrol Plc

 

David Traynor, Chief Executive

+44 (0)1925 742 000

Nic Hellyer, Chief Financial Officer

 

 

 

finnCap Limited (Nominated Adviser and Broker)

+44 (0)20 7220 0500

Geoff Nash/Kate Bannatyne - Corporate Finance

 

Richard Chambers - ECM

 

 

 

Flagstaff Strategic and Investor Communications

+44 (0)20 7129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon 

 

byotrol@flagstaffcomms.com

 

 

 

 

Notes to editors

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

 

Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.

 

For more information, go to byotrol.co.uk

 

 

The below notification is made in accordance with the requirements of the EU Market Abuse Regulation.

1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

David Traynor

2. 

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial Notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Byotrol plc

b)

LEI:

213800AJMTSTIPA59A34

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 0.25 pence per share

GB00B0999995

b)

Nature of the transaction:

Purchase of Shares

 

c)

Price(s) and volume(s):

Price(s)

Volume(s)

4.29p

244,155

 

 

 

d)

Aggregated information:

·Aggregated volume:

·Price:

See 4c) above

 

e)

Date of the transaction:

08/12/2021

f)

Place of the transaction:

AIM, London Stock Exchange (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDZMGZRLNGMZG
Date   Source Headline
20th Aug 20151:00 pmRNSPlacing and Subscription to raise £1.4 million
14th Aug 20157:00 amRNSPosting of Annual Report and Notice of AGM
4th Aug 20157:00 amRNSAgreement with Solvay
1st Jul 20158:25 amRNSHolding(s) in Company
15th Jun 20157:00 amRNSPreliminary Results
16th Apr 20157:00 amRNSTrading update
25th Nov 20147:01 amRNSInterim Results
25th Nov 20147:00 amRNSBoard Appointment
10th Nov 201410:58 amRNSNotice of Interim Results
17th Sep 20141:08 pmRNSHolding(s) in Company
29th Jul 20143:35 pmRNSResult of AGM and Completion of Placing
24th Jul 20147:00 amRNSGrant of Options
7th Jul 20147:00 amRNSANNUAL REPORT AND AGM NOTICE
25th Jun 20147:00 amRNSConditional Fundraising of £1.25m
25th Jun 20147:00 amRNSUnaudited Preliminary Results
18th Mar 20147:00 amRNSTrading Update and Directorate Changes
20th Dec 20137:00 amRNSFundraising
19th Nov 20137:00 amRNSInterim Results
31st Oct 20137:00 amRNSTotal Voting Rights
17th Oct 20133:04 pmRNSHolding(s) in Company
10th Oct 20133:11 pmRNSHolding(s) in Company
9th Oct 20137:00 amRNSDirectorate Change
3rd Oct 20137:00 amRNSAcquisition
15th Aug 20138:34 amRNSDirector/PDMR Shareholding
13th Aug 20133:12 pmRNSDirector/PDMR Shareholding
9th Aug 20132:47 pmRNSDirector/PDMR Shareholding
9th Aug 20138:20 amRNSHolding(s) in Company
25th Jul 20133:54 pmRNSResult of AGM
1st Jul 20139:28 amRNSDirector/PDMR Shareholding
25th Jun 20137:01 amRNSIssue of Equity
25th Jun 20137:00 amRNSFinal Results
19th Apr 20137:00 amRNSDirectorate Change
19th Mar 20137:00 amRNSJDA with Albaad Ltd for UK & Europe
8th Feb 20137:00 amRNSCommercial & Trading Update
20th Nov 20127:00 amRNSInterim Results
1st Oct 20129:44 amRNSDirector/PDMR Shareholding
16th Aug 201210:25 amRNSDirector/PDMR Shareholding
14th Aug 20126:08 pmRNSHolding(s) in Company
13th Aug 20127:00 amRNSLicensing Agreement with Kimberly-Clark
25th Jul 20127:00 amRNSHolding(s) in Company
23rd Jul 20128:03 amRNSHolding(s) in Company
19th Jul 20123:33 pmRNSResult of AGM
19th Jul 20127:00 amRNSAGM Statement
17th Jul 201211:10 amRNSDirector/PDMR Shareholding
6th Jul 20127:00 amRNSGrant of Options
27th Jun 20127:00 amRNSDirectorate Change + Annual Report + AGM notice
19th Jun 20127:00 amRNSPreliminary Results
12th Apr 20127:00 amRNSTrading Update
10th Feb 201210:54 amRNSHolding(s) in Company
31st Jan 20122:00 pmRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.